Objectives: Hürthle cells (HCs) are follicular-derived oncocytic cells seen in a variety of neoplastic and nonneoplastic pathologic entities of the thyroid gland. This study was to report our experience of the surgical outcome on the finding of HCs on fine-needle aspiration biopsies (FNABs) of thyroid nodules, to identify cytologic predictors of HC neoplasms and an attempt to overcome diagnostic pitfalls. Study Design: This was a retrospective study of all FNAB of thyroid nodules with findings of HCs with subsequent surgical resection. The FNAB slides of 70 thyroid nodules were blindly reviewed for specific cytomorphologic characteristics. The cytologic findings were correlated with the corresponding final surgical pathology diagnosis. Results: The patients ranged in age from 25 to 78 years with a male:female ratio of 1:2. There were 19 false-negative and 4 false-positive cases. Overall high cellularity, scant colloid and >90% HCs on FNAB are consistently seen in a neoplastic HC process. All cases of Hashimoto's thyroiditis were associated with prominent nucleoli and 92% of cases demonstrating transgressing vessels were neoplastic. Conclusion: Diagnostic accuracy can be improved by following the current Bethesda classification system. A constellation of cytomorphologic features in conjunction with clinical findings can be considered a strong predictor of a neoplastic process.

Keywords:
Hürthle cell, Fine-needle aspiration biopsy, Thyroid
1.
Montone KT, Baloch ZW, LiVolsi VA: The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med 2008;132:1241-1250.
2.
Kauffmann PR, Dejax C, de Latour M, Dauplat J: The meaning and predictivity of Hürthle cells in fine needle aspiration cytology for thyroid nodular disease Eur J Surg Oncol 2004;30:786-789.
3.
Giorgadze T, Rossi ED, Fadda G, Gupta PK, Livolsi VA, Baloch Z: Does the fine-needle aspiration diagnosis of ‘Hürthle-cell neoplasm/follicular neoplasm with oncocytic features' denote increased risk of malignancy? Diagn Cytopathol 2004;31:307-312.
4.
Renshaw AA: Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria. Cancer 2002;96:261-266.
5.
Elliott DD, Pitman MB, Bloom L, Faquin WC: Fine-needle aspiration biopsy of Hürthle cell lesions of the thyroid gland. A cytomorphologic study of 139 cases with statistical analysis. Cancer Cytopathol 2006;108:102-109.
6.
Nguyen GK, Husain M, Akin MRM: Cytodiagnosis of benign and malignant Hürthle cell lesions of the thyroid by fine-needle aspiration biopsy. Diagn Cytopathol 1999;20:261-265.
7.
Clark DP, Faquin WC, Hurthle cell lesions; in Rosenthal DL (ed): Essentials in Cytopathology. New York, Springer, 2005, pp 88-102.
8.
Khan A, Nose V: Pathology of thyroid gland; in Lloyd RV (ed): Endocrine Pathology: Differential Diagnosis and Molecular Advances. New York, Springer, 2010, pp 181-235.
9.
Kitamura Y, et al: Follicular carcinoma; in DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds): World Health Organization Classification of Tumors, Pathology and Genetics: Tumors of Endocrine Organs. Lyon, IARC Press, 2004, pp 67-72.
10.
Ravinsky E, Safnek JR: Differentiation of Hashimoto's thyroiditis from thyroid neoplasms in fine needle aspirates. Acta Cytol 1988;32:854-861.
11.
Wu HH, Clouse J, Ren R: Fine-needle aspiration cytology of Hürthle cell carcinoma of the thyroid. Diagn Cytopathol 2008;36:149-154.
12.
Lee J, Hasteh F: Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: a case report and review of the literature. Diagn Cytopathol 2009;37:600-606.
13.
Tseng CE, Wei CK, Kuo CS, Yan ST, Chen PF, Lien WC, Chang SM, Su TC, Tseng YH: Fine needle aspiration cytology of thyroid nodules: evaluation of diagnostic accuracy. Tzu Chi Med J 2008;20:296-303.
14.
Jogai S, Al-Jassar A, Temmim L, Dey P, Adesina AO, Arnanguno HG: Fine needle aspiration cytology of the thyroid: a cytohistologic study with evaluation of discordant cases. Acta Cytol 2005;49:483-488.
15.
Harvey AM, Truong LD, Mody DR: Diagnostic pitfalls of Hashimoto's/lymphocytic thyroiditis on fine-needle aspirations and strategies to avoid overdiagnosis. Acta Cytol 2012;56:352-360.
16.
Haberal AN, Toru S, Ozen O, Arat Z, Bilezikci B: Diagnostic pitfalls in the evaluation of fine-needle aspiration cytology of the thyroid: correlation with histopathology in 260 cases. Cytopathology 2009;20:103-108.
17.
MacDonald L, Yazdi HM: Fine needle aspiration biopsy of Hashimoto's thyroiditis. Sources of diagnostic error. Acta Cytol 1999;43:400-406.
18.
Nguyen GK, Ginsberg J, Crockford PM, Villanueva RR: Hashimoto's thyroiditis cytodiagnostic accuracy and pitfalls. Diagn Cytopathol 1997;16:531-536.
19.
DeMay RM: Thyroid; in: The Art and Science of Cytopathology. Chicago, American Society of Clinical Pathologists, 1996, pp 738-740.
20.
Ylagan LR, Farkas T, Dehner LP: Fine needle aspiration of the thyroid: a cytohistologic correlation and study of discrepant cases. Thyroid 2004;14:35-41.
21.
Yang GCH, Schreiner AM, Sun W: Can abundant colloid exclude oncocytic (Hürthle cell) carcinoma in thyroid fine needle aspiration? Cytohistological correlation of 127 oncocytic (Hürthle cell) lesions. Cytopathology 2013;24:185-193.
22.
Nikiforov YE: Recent developments in the molecular biology of the thyroid; in Lloyd RV (ed): Endocrine Pathology: Differential Diagnosis and Molecular Advances. New York, Springer, 2010, pp 237-260.
23.
Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris L, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN: Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 2011;96:3390-3397.
24.
Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C: BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance. Acta Cytol 2011;55:570-575.
25.
Colanta A, Lin O, Tafe L, Ghossein R, Khedoudja N, Mitchell T, Ladanyi M, Arcila M: BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis. Acta Cytol 2011;55:563-569.
26.
Smith GD, Zhou L, Rowe LR, Jarboe EA, Collins BT, Bentz JS, Wittwer CT, Chadwick BE: Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine needle aspiration specimens. Acta Cytol 2011;55:576-583.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.